Screening for trisomy 21 based on maternal age, nuchal translucency measurement, first trimester biochemistry and quantitative and qualitative assessment of the flow in the DV - the assessment of efficacy.
暂无分享,去创建一个
B. Czuba | M. Wielgoś | G. Bręborowicz | P. Węgrzyn | K. Sodowski | D. Borowski | M. Dubiel | M. Mączka | W. Cnota | Dawid Serafin | A. Kubaty | D. Zarotyński | Małgorzata Reska-Nycz